SuperSonic Imagine showcases ultrasound innovations at European Congress of Radiology
AIX-EN-PROVENCE, FRANCE, 1 March 2016 – SuperSonic Imagine (Euronext: SSI, FR0010526814), the highly innovative ultrasound company, announced today its participation in the European Congress of Radiology (ECR) March 2 - 6, in Vienna, Austria, to demonstrate the clinical benefits of real-time ShearWave™ Elastography (SWE™) in assessing major diseases such as chronic liver disease and cancer of the breast, prostate and thyroid as well as in the domain of musculoskeletal imaging.
SuperSonic Imagine will showcase its new solution for microvascular visualization, Angio PL.U.S. – Planewave UltraSensitiveTM imaging. Angio PL.U.S. is a significant advancement in Color Doppler Imaging. Conventional Doppler is limited in its ability to show microvascular slow flow. Angio PL.U.S. provides a new level of microvascular imaging through significantly improved color sensitivity and spatial resolution while maintaining exceptional 2D imaging. It increases the detail of real-time flow information available during ultrasound diagnostic exams. This information is instrumental in helping the diagnosis of cancerous tissues in areas such as the liver, lymph nodes and thyroid as well as musculoskeletal pathologies such as inflammation in tendons. Angio PL.U.S. leverages SuperSonic Imagine’s previous innovation, UltraFastTM Doppler, providing an advanced solution for vascular evaluation.